跳至主要内容
临床试验/NL-OMON37436
NL-OMON37436招募中不适用

Anticoagulation bridging: the substitution of sintrom by heparin in the periprocedural period: the Brug study - the Brug study

Philips Research0 个研究点目标入组 36 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
36

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Chronic, more than 3 months VKA use
  • Acenocoumarol use
  • An invasive procedure is planned (scopy or small intervention)
  • The patient is bridged with heparin

排除标准

  • Renal failure (MDRD clearance < 30 ml/min/1.73m2)
  • Heparin induced thrombocytopenia (HIT)
  • Documented contra indication for heparin
  • Emergency procedures

研究者

相似试验

招募中
3 期
The effect of systemic anticoagulants in repairing penetrating upper limb arterial traumaArterial trauma.I23.6
IRCT20190717044255N3Arak University of Medical Sciences116
已完成
2 期
the effect of plavix in post coronary artery bypass graft/coronary endarterectomy patientsCoronary artery disease.Atherosclerotic heart disease Coronary (artery): atheroma atherosclerosis disease sclerosis
IRCT2016102730410N2Babol University of Medical Sciences, Deputy of Research & Technology55
进行中(未招募)
1 期
Substitution of coagulation factors and blood products in patients with liver cirrhosisiver cirrhosisMedDRA version: 20.0Level: LLTClassification code 10024667Term: Liver cirrhosisSystem Organ Class: 100000004871
EUCTR2021-006870-22-ATMedical University of Vienna400
进行中(未招募)
1 期
Optimal anticoagulation for patients with an increased risk for stroke after treatment of an heart arrhythmia (atrial fibrillation) by catheter ablatiorisk of stroke by atrial fibrillationMedDRA version: 20.0Level: PTClassification code 10003658Term: Atrial fibrillationSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 22.1Level: PTClassification code 10014498Term: Embolic strokeSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.0Level: PTClassification code 10059864Term: Cardiac ablationSystem Organ Class: 10042613 - Surgical and medical procedures
EUCTR2016-002353-38-DEOttawa Heart Institute Research Corporation (OHIRC)1,572
进行中(未招募)
1 期
OCEA
EUCTR2016-002353-38-BEOttawa Heart institute Research Corporation1,284
Anticoagulation bridging: the substitution of... | 临床试验